Filter
1077
Text search:
drug
promotion
Featured
116
522
Language
Document type
961
53
24
15
14
5
3
1
1
Countries
87
67
54
53
47
46
45
40
36
34
33
28
26
26
21
21
18
17
15
15
12
9
8
8
6
6
6
6
5
4
4
4
4
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
683
69
68
50
30
15
10
1
Toolboxes
115
28
27
26
24
21
21
20
15
12
12
11
7
6
5
4
4
3
2
2
Act 851 | AN ACT to revise and consolidate the law relating to public health to
prevent disease, promote, safeguard, maintain and protect the health
of humans and animals and to provide for related matters.
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve
...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Accessed November 2017.
Good practice guide
Supporting community action on HIV, health and rights to end AIDS
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
Working Document, September 2017
A Handbook for country programmes
Rapport de plaidoyer Mars 2011
303100 03/2011 E 1,000
NHSP 2017- 2022 (Final draft)
Overcoming Barriers to TB Control
Training Curriculum
August 2011
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
Rapport sur les populations clés.
